Management Quality -- 8/10
Sanjay Mehrotra has led Micron since May 2017 (9 years), navigating the brutal FY2023
downturn (revenue cut nearly in half, $5.8B net loss) with discipline -- cutting capex,
maintaining R&D -- and positioning the company perfectly for the AI-driven upcycle.
The HBM ramp has been executed flawlessly, with Micron achieving technology leadership
(industry-first HBM4 volume shipments, first 1-gamma DRAM). Guidance beats have been
massive and consecutive: FQ2 2026 revenue came in 28% above the high end of guide,
EPS 45% above. The introduction of multiyear Strategic Customer Agreements and a 30%
dividend increase signal confidence in the durability of the cycle.
Weight: 20%
CEO Tenure
9 Years
Sanjay Mehrotra, CEO since May 2017
Guidance Beats
6/6 Consecutive
Every metric beat for 2 straight quarters
FQ2 2026 EPS Beat
+45%
$12.20 actual vs $8.62 high end of guide
Dividend Increase
+30%
Signals confidence in cycle durability
Promise vs. Delivery Tracker
| When Promised | Promise | Evidence | Status |
|---|---|---|---|
| FQ4 2025 (Sep 2025) | FQ1 2026 revenue $12.5B +/- $300M | Actual $13.6B (well above high end) | BEAT |
| FQ4 2025 | FQ1 2026 gross margin ~51.5% | Actual 56.8% (500bp above guide) | BEAT |
| FQ4 2025 | FQ1 2026 EPS ~$3.75 +/- $0.15 | Actual $4.78 (27% above high end) | BEAT |
| FQ1 2026 (Dec 2025) | FQ2 2026 revenue $18.7B +/- $400M | Actual $23.9B (28% above high end) | BEAT |
| FQ1 2026 | FQ2 2026 gross margin ~68% +/- 100bp | Actual 75% (700bp above guide) | BEAT |
| FQ1 2026 | FQ2 2026 EPS ~$8.42 +/- $0.20 | Actual $12.20 (45% above high end) | BEAT |
| FQ4 2025 | HBM share in line with DRAM share by CQ3 2025 | Confirmed on FQ4 2025 call | MET |
| FQ4 2025 | FY2026 capex ~$18B | Revised up to $25B+ (demand stronger) | REVISED UP |
| FQ1 2026 | HBM TAM CAGR ~40% to ~$100B by 2028 | Not revised downward; on track | ON TRACK |
| FQ1 2026 | Expect sell-out of CY2026 HBM supply | Confirmed all CY2026 HBM supply sold | MET |
| FQ2 2026 | First 5-year SCA signed | Announced in FQ2 call | MET |
| FQ4 2025 | 1-gamma mature yields in record time | Fastest ramp to mature yields; majority of DRAM bits by mid-CY2026 | MET |
12 of 12 promises delivered, beat, or met. 1 on track (HBM TAM forecast). 1 revised upward
(capex from $18B to $25B+, demand-justified). Management demonstrates a pattern of
conservative guidance with massive upside delivery.
Source: Daloopa, earnings call transcripts FQ4 2025 - FQ2 2026.
Massive Guidance Beats
The magnitude of recent guidance beats is extraordinary and historically unusual even
for a cyclical semiconductor company. This suggests either genuinely extraordinary
demand acceleration or conservative sandbagging -- both of which reflect well on
management credibility.
| Metric | Guidance | Actual | Beat |
|---|---|---|---|
| FQ1 2026 Revenue | $12.5B +/- $300M | $13.6B | +6% vs midpoint |
| FQ1 2026 Gross Margin | ~51.5% | 56.8% | +530bp |
| FQ1 2026 EPS | $3.75 +/- $0.15 | $4.78 | +27% vs high end |
| FQ2 2026 Revenue | $18.7B +/- $400M | $23.9B | +28% vs high end |
| FQ2 2026 Gross Margin | ~68% +/- 100bp | 75% | +700bp |
| FQ2 2026 EPS | $8.42 +/- $0.20 | $12.20 | +45% vs high end |
Source: Daloopa, Micron earnings releases FQ1-FQ2 2026.
Red Flags
Capex Revision: $18B to $25B+
FY2026 capex guidance was originally ~$18B (FQ4 2025), revised to ~$20B (FQ1 2026), then above $25B (FQ2 2026). FY2027 capex to step up "meaningfully" with construction spend up $10B+ YoY. This is the biggest concern. History shows memory companies tend to over-invest at cycle peaks -- from FY2022 peak ($8.35 EPS) to FY2023 trough ($-4.45 EPS) was a 152% swing.
FY2026 capex guidance was originally ~$18B (FQ4 2025), revised to ~$20B (FQ1 2026), then above $25B (FQ2 2026). FY2027 capex to step up "meaningfully" with construction spend up $10B+ YoY. This is the biggest concern. History shows memory companies tend to over-invest at cycle peaks -- from FY2022 peak ($8.35 EPS) to FY2023 trough ($-4.45 EPS) was a 152% swing.
Mitigating factors: Customers are receiving only 50-65% of their memory
demand due to supply constraints. Greenfield fab construction takes 3+ years, limiting
supply response. The introduction of 5-year Strategic Customer Agreements may provide
downside margin protection (though terms remain confidential). Sanjay Mehrotra navigated
the FY2023 downturn with capital discipline, providing some comfort that the current ramp
is demand-justified rather than speculative.
No other material red flags identified. All 12 tracked promises were delivered, beat, or met.
Score Rationale
8/10. Sanjay Mehrotra has delivered exceptional performance over this
cycle. He navigated the brutal FY2023 downturn (revenue cut nearly in half, $5.8B net
loss) with discipline and positioned the company perfectly for the AI-driven upcycle.
The HBM ramp has been executed flawlessly -- industry-first HBM4 volume shipments,
fastest 1-gamma DRAM ramp to mature yields. Guidance beats have been massive and
consecutive: FQ2 2026 revenue 28% above high end, EPS 45% above. The introduction
of multiyear SCAs with specific commitments is a potential structural improvement
to the business model. The 30% dividend increase signals confidence. CFO Mark Murphy
(since 2022) is newer but has overseen this period of record execution. The score
is held below 9 by the aggressive capex trajectory -- $25B+ in FY2026 with a
"meaningful step-up" in FY2027 -- which echoes historical patterns of memory
over-investment at cycle peaks. That said, management has earned credibility through
the FY2023 downturn and the track record of conservative guidance with massive
upside delivery.
Data sourced from Daloopa, earnings call transcripts, and company filings.